Healthcare Market Research Reports Analysis and Trends

Publication Single User License (PDF) Price
Opportunity in the Indian Life Science Industry - 2013

Opportunity in the Indian Life Science Industry - 2014

Date Published: Jan 17 2014

This report provides an insight into the Opportunity in the Indian Life Science Industry current scenario, structure and practices.

In depth Healthcare market scenario includes;
a. Healthcare Market - 2011 to 2018
b. Trends in disease burden - 1990, 2008 and 2013
c. Treatment of lifestyle diseases is expensive - Maternity, Injuries, Lifestyle Dieseases
d. India Infra vs. Global - Beds, Nurses, Physicians
e. Bed Density - 2001, 2007, 2010, 2012, 2022

$12,000.00
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

Date Published: Jan 31 2014
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines Global Drug Forecast and Market Analysis to 2022
Prophylactic Hepatitis B Virus Vaccines Global sales to reach over $1.1 billion by 2022.
$10,995.00
PharmaPoint: Postmenopausal Vaginal Atrophy - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - Global Drug Forecast and Market Analysis to 2022

Date Published: Jul 31 2013

PharmaPoint: Postmenopausal Vaginal Atrophy - Global Drug Forecast and Market Analysis to 2022

Summary

$10,995.00
PharmaPoint: Obesity - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Obesity - Global Drug Forecast and Market Analysis to 2022

Date Published: Oct 31 2013

PharmaPoint: Obesity - Global Drug Forecast and Market Analysis to 2022

Summary

$10,995.00
PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

Date Published: Jan 31 2014
$10,995.00
PharmaPoint: Meningococcal Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update

PharmaPoint: Meningococcal Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update

Date Published: Aug 31 2013

PharmaPoint: Meningococcal Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update

Summary

$10,995.00
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022

Date Published: Oct 31 2013

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022

Summary

$10,995.00
PharmaPoint: HIV - Global Drug Forecast and Market Analysis to 2022 Event Driven Update

PharmaPoint: HIV - Global Drug Forecast and Market Analysis to 2022 Event Driven Update

Date Published: Mar 31 2013

PharmaPoint: HIV - Global Drug Forecast and Market Analysis to 2022 Event Driven Update

Summary

$10,995.00
PharmaPoint: Crohn’s Disease - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Crohn’s Disease - Global Drug Forecast and Market Analysis to 2022

Date Published: Jan 31 2014
The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon, such as - 
  • Takeda’s alpha4beta7 inhibitor, Entyvio (vedolizumab)
  • Johnson & Johnson’s (J&J’s) interleukin (IL)-12/23 inhibitor, Stelara (ustekinumab)
 
$10,995.00
PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update

PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update

Date Published: Sep 30 2013

PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update

Summary

$10,995.00
PharmaPoint: Atopic Dermatitis - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Atopic Dermatitis - Global Drug Forecast and Market Analysis to 2022

Date Published: Nov 30 2013
PharmaPoint: Atopic Dermatitis Global Drug Forecast and Market Analysis to 2022
 

Summary

Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for others to follow suit. 
 
$10,995.00
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022

Date Published: Feb 28 2014
PharmaPoint: Ulcerative Colitis Global Drug Forecast and Market Analysis to 2022
Global ulcerative colitis (UC) market is expected to reached $6.6 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 4.7%.
 

Summary

$10,995.00
PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update

PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update

Date Published: Apr 30 2013

PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update

Summary

$10,995.00
PharmaPoint: Chronic Myeloid Leukemia (CML) - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - Global Drug Forecast and Market Analysis to 2022

Date Published: May 31 2013

PharmaPoint: Chronic Myeloid Leukemia (CML) - Global Drug Forecast and Market Analysis to 2022

Summary

$10,995.00
PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022

Date Published: Nov 30 2013

PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022

Summary

$10,995.00
PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Analysis to 2022

Date Published: May 31 2013

PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Analysis to 2022

Summary

The Dry Eye Syndrome (DES) pipeline is strong, with 49 molecules in various phases of development. More notably, the late-stage pipeline has three products with novel mechanisms of action to treat the inflammation associated with the disease. That said, physicians suggest that the largest unmet need for DES treatment is diagnosis.

Highlights

Key Questions Answered

$10,995.00
PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022

Date Published: May 31 2013

PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022

Summary

$10,995.00
PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

Date Published: Dec 31 2013

PharmaPoint: Epilepsy Global Drug Forecast and Market Analysis to 2022 Event-Driven Update

 

Summary

$10,995.00
PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

Date Published: Apr 30 2014

PharmaPoint: Non-Small Cell Lung Cancer Global Drug Forecast and Market Analysis to 2022 Event-Driven Update

 

Summary

$10,995.00
PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022

Date Published: Dec 31 2013
PharmaPoint: Microvascular Complications of Diabetes Global Drug Forecast and Market Analysis to 2022
 
$10,995.00

Pages

Shopping cart

0 Items $0.00
Market Research Special Offers
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data